Dicerna Pharmaceuticals, Inc., A Novo Nordisk Company
Clinical trials sponsored by Dicerna Pharmaceuticals, Inc., A Novo Nordisk Company, explained in plain language.
-
Experimental cancer drug tested in patients out of options
Disease control CompletedThis early-stage study tested a new drug called DCR-STAT3 in adults with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and how the body processes it in 26 participants. Researchers also looked for early sign…
Phase: PHASE1 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for kids with rare kidney disease
Disease control CompletedThis study tested a drug called nedosiran in children from birth to 11 years old who have primary hyperoxaluria, a rare genetic disease that causes kidney stones and can lead to kidney failure. The main goal was to see if the monthly treatment safely lowers the harmful oxalate le…
Phase: PHASE2 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Early test: can new drug make drinking unpleasant to curb alcohol problems?
Disease control CompletedThis early-stage study tested the safety of an experimental drug called DCR-AUD in healthy adults who are social drinkers. Researchers gave participants multiple doses to see how their bodies handled the drug and what side effects occurred, especially when combined with alcohol i…
Phase: PHASE1 • Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC